Caveolin-1: a multifaceted driver of breast cancer progression and its application in clinical treatment
Open Access
- 1 February 2019
- journal article
- review article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 12, 1539-1552
Abstract
Human breast cancer is one of the most frequent cancer diseases and causes of death among female population worldwide. It appears at a high incidence and has a high malignancy, mortality, recurrence rate and poor prognosis. Caveolin-1 (Cav1) is the main component of caveolae and participates in various biological events. More and more experimental studies have shown that Cav1 plays a critical role in the progression of breast cancer including cell proliferation, apoptosis, autophagy, invasion, migration and breast cancer metastasis. Besides, Cav1 has been found to be involved in chemotherapeutics and radiotherapy resistance, which are still the principal problems encountered in clinical breast cancer treatment. In addition, stromal Cav1 may be a potential indicator for breast cancer patients’ prognosis. In the current review, we cover the state-of-the-art study, development and progress on Cav1 and breast cancer, altogether describing the role of Cav1 in breast cancer progression and application in clinical treatment, in the hope of providing a basis for further research and promoting CAV1 gene as a potential target to diagnose and treat aggressive breast cancers.Keywords
This publication has 163 references indexed in Scilit:
- Caveolin-1 Regulates Endothelial Adhesion of Lung Cancer Cells via Reactive Oxygen Species-Dependent MechanismPLOS ONE, 2013
- Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and SenescenceCell, 2012
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosisNature, 2010
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong RemissionCancer Research, 2009
- Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotypeBritish Journal of Cancer, 2008
- Caveolin-1 Up-regulation during Epithelial to Mesenchymal Transition Is Mediated by Focal Adhesion KinaseJournal of Biological Chemistry, 2008
- Breast Cancer Progression: Controversies and Consensus in the Molecular Mechanisms of Metastasis and EMTJournal of Mammary Gland Biology and Neoplasia, 2007
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001